Lloyds Banking Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-6,623
Closed -$1.6M 446
2014
Q3
$1.6M Sell
6,623
-535
-7% -$120K 0.44% 64
2014
Q2
$1.6M Sell
7,158
-54,777
-88% -$11.3M 0.39% 76
2014
Q1
$12.7M Buy
61,935
+306
+0.5% +$60.6K 0.11% 197
2013
Q4
$10.4M Buy
61,629
+30,835
+100% +$4.82M 0.09% 208
2013
Q3
$4.43M Sell
30,794
-1,110
-3% -$148K 0.05% 286
2013
Q2
$4.03M Buy
+31,904
New +$3.61M 0.04% 284

Other funds holding AGN

Lloyds Banking Group's AGN Position: Q4 2014 in Review

Lloyds Banking Group sold out of Allergan plc (AGN) in Q4 2014, closing a stake of 6,623 shares — an estimated $1.6M sold.

Lloyds Banking Group first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $12.7M in Q1 2014. 840 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Lloyds Banking Group reported no remaining Allergan plc position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 6,623 Allergan plc shares in Q4 2014, an estimated $1.6M.
  • Lloyds Banking Group first reported a position in Allergan plc in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's Allergan plc position peaked at $12.7M in Q1 2014.
  • 840 funds tracked by Wall St. Rank held Allergan plc as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.